ConductScience.org, home

Paper39337273

Myosin Isoform-Dependent Effect of Omecamtiv Mecarbil on the Regulation of Force Generation in Human Cardiac Muscle.

Scellini B and 6 others. Int J Mol Sci, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Myosin Isoform-Dependent Effect of Omecamtiv Mecarbil on the Regulation of Force Generation in Human Cardiac Muscle. Papers, record 39337273. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337273

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myosin Isoform-Dependent Effect of Omecamtiv Mecarbil on the Regulation of Force Generation in Human Cardiac Muscle.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.79, provisional
iCite
Revised in PubMed
2024-10-04
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scellini BBeatricehttps://orcid.org/0000-0003-3980-683X
2Piroddi NNicolettahttps://orcid.org/0000-0001-8424-9054
3Dente MMarica
4Pioner JMJ Manuelhttps://orcid.org/0000-0003-0179-3033
5Ferrantini CCecilia
6Poggesi CCorradohttps://orcid.org/0000-0003-2624-4778
7Tesi CChiarahttps://orcid.org/0000-0002-1111-1473

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
UreaMajor topic
MyofibrilsMajor topic
Myocardial ContractionMajor topic
Humans
Calcium
Myocardium
Protein Isoforms
Myosins
Heart Ventricles
Male
Cardiac Myosins
Female
Adult

Source PubMed

Download CSV of topics

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127012405Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.J Am Coll Cardiol2016https://conductscience.org/library/papers/27012405PubMed
210827985The effect of inorganic phosphate on force generation in single myofibrils from rabbit skeletal muscle.Biophys J2000https://conductscience.org/library/papers/10827985PubMed
318617566Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts.J Physiol2008https://conductscience.org/library/papers/18617566PubMed
435534374Sarcomere protein modulation: The new frontier in cardiovascular medicine and beyond.Eur J Intern Med2022https://conductscience.org/library/papers/35534374PubMed
535852543Omecamtiv Mecarbil as a Therapy for Heart Failure With Low Ejection Fraction.JAMA2022https://conductscience.org/library/papers/35852543PubMed
621415352Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.Science2011https://conductscience.org/library/papers/21415352PubMed
726140433The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.Br J Pharmacol2015https://conductscience.org/library/papers/26140433PubMed
838566963Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future.Front Cardiovasc Med2024https://conductscience.org/library/papers/38566963PubMed
930242219Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the myosin working stroke.Nat Commun2018https://conductscience.org/library/papers/30242219PubMed
1021856480Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study.Lancet2011https://conductscience.org/library/papers/21856480PubMed
1133891673Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle.J Gen Physiol2021https://conductscience.org/library/papers/33891673PubMed
1215621050Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue.Cardiovasc Res2005https://conductscience.org/library/papers/15621050PubMed
132966401Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2966401PubMed
1424878771Sex differences in myosin heavy chain isoforms of human failing and nonfailing atria.Am J Physiol Heart Circ Physiol2014https://conductscience.org/library/papers/24878771PubMed
1534704115Alpha and beta myosin isoforms and human atrial and ventricular contraction.Cell Mol Life Sci2021https://conductscience.org/library/papers/34704115PubMed
169530220Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species.Am J Physiol1998https://conductscience.org/library/papers/9530220PubMed
1726246073Structural basis for drug-induced allosteric changes to human β-cardiac myosin motor activity.Nat Commun2015https://conductscience.org/library/papers/26246073PubMed
1831103235Omecamtiv Mecarbil Slows Myosin Kinetics in Skinned Rat Myocardium at Physiological Temperature.Biophys J2019https://conductscience.org/library/papers/31103235PubMed
198307894Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms.J Appl Physiol (1985)1993https://conductscience.org/library/papers/8307894PubMed
2035852527Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.JAMA2022https://conductscience.org/library/papers/35852527PubMed

See all 48 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42289718Targeting cardiac myosin in HFrEF: mechanism, clinical evidence, and the role of omecamtiv mecarbil.J Cardiothorac Surg2026https://conductscience.org/library/papers/42289718PubMed
41858918Cardiac Myosin Activators in Heart Failure: Experimental Advances Amid Clinical Uncertainty.Drug Des Devel Ther2026https://conductscience.org/library/papers/41858918PubMed
40313875Mechanistic insights into effects of the cardiac myosin activator omecamtiv mecarbil from mechanokinetic modelling.Front Physiol2025https://conductscience.org/library/papers/40313875PubMed
40142759Eligibility of Outpatients with Chronic Heart Failure for Vericiguat and Omecamtiv Mecarbil: From Clinical Trials to the Real-World Practice.J Clin Med2025https://conductscience.org/library/papers/40142759PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MYH1479784PubTator's text mininghttps://conductscience.org/library/genes/79784NCBI Gene
MYH64624PubTator's text mininghttps://conductscience.org/library/genes/4624NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39337273

GET https://conductscience.org/api/papers/v1/39337273/references?page=2